prikaz prve stranice dokumenta A Phase 2, International, Multicenter, Open-label Clinical Trial of Subcutaneous Tbo-Filgrastim in Pediatric Patients With Solid Tumors Undergoing Myelosuppressive Chemotherapy
Rad nije dostupan
Znanstveni rad - Izvorni znanstveni rad
A Phase 2, International, Multicenter, Open-label Clinical Trial of Subcutaneous Tbo-Filgrastim in Pediatric Patients With Solid Tumors Undergoing Myelosuppressive Chemotherapy
Journal of Pediatric Hematology/Oncology, 41 (2019), 7; 525-531. https://doi.org/10.1097/mph.0000000000001542

Federman, Noah; Dragomir, Monica D.; Kizyma, Zoryana; Roganovic, Jelena; Bias, Peter; Lammerich, Andreas; Ben Arie, Zipi R.; Zou, Linglong; Hoehn, Gerald; Buchner, Anton

Citirajte ovaj rad

Federman, N., Dragomir, M. D., Kizyma, Z., Roganovic, J., Bias, P., Lammerich, A. ... Buchner, A. (2019). A Phase 2, International, Multicenter, Open-label Clinical Trial of Subcutaneous Tbo-Filgrastim in Pediatric Patients With Solid Tumors Undergoing Myelosuppressive Chemotherapy. Journal of Pediatric Hematology/Oncology, 41. (7), 525-531. doi: 10.1097/mph.0000000000001542

Federman, Noah, et al. "A Phase 2, International, Multicenter, Open-label Clinical Trial of Subcutaneous Tbo-Filgrastim in Pediatric Patients With Solid Tumors Undergoing Myelosuppressive Chemotherapy." Journal of Pediatric Hematology/Oncology, vol. 41, br. 7, 2019, str. 525-531. https://doi.org/10.1097/mph.0000000000001542

Federman, Noah, Monica D. Dragomir, Zoryana Kizyma, Jelena Roganovic, Peter Bias, Andreas Lammerich, Zipi R. Ben Arie, Linglong Zou, Gerald Hoehn i Anton Buchner. "A Phase 2, International, Multicenter, Open-label Clinical Trial of Subcutaneous Tbo-Filgrastim in Pediatric Patients With Solid Tumors Undergoing Myelosuppressive Chemotherapy." Journal of Pediatric Hematology/Oncology 41, br. 7 (2019): 525-531. https://doi.org/10.1097/mph.0000000000001542

Federman, N., et al. (2019) 'A Phase 2, International, Multicenter, Open-label Clinical Trial of Subcutaneous Tbo-Filgrastim in Pediatric Patients With Solid Tumors Undergoing Myelosuppressive Chemotherapy', Journal of Pediatric Hematology/Oncology, 41(7), str. 525-531. doi: 10.1097/mph.0000000000001542

Federman N, Dragomir MD, Kizyma Z, Roganovic J, Bias P, Lammerich A, i sur.. A Phase 2, International, Multicenter, Open-label Clinical Trial of Subcutaneous Tbo-Filgrastim in Pediatric Patients With Solid Tumors Undergoing Myelosuppressive Chemotherapy. Journal of Pediatric Hematology/Oncology [Internet]. 2019. [pristupljeno 18.07.2024.];41(7):525-531. doi: 10.1097/mph.0000000000001542

N. Federman, et al., "A Phase 2, International, Multicenter, Open-label Clinical Trial of Subcutaneous Tbo-Filgrastim in Pediatric Patients With Solid Tumors Undergoing Myelosuppressive Chemotherapy", Journal of Pediatric Hematology/Oncology, vol. 41, br. 7, str. 525-531, 2019. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:771828. [Citirano: 18.07.2024.]